Use of allosteric hemoglobin modifiers in combination with radia

Details Use of allosteric hemoglobin modifiers in combination with radia Use of allosteric hemoglobin modifiers in combination with radia

1995-06-07

1998-01-06

Nazario-Gonzalez, Porfirio

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514486, 514512, 514513, 514533, 514535, 514538, 514833, 548403, 548416, 548473, 548478, 560 30, 560 31, 560 32, 562425, 562452, 562455, 568452, 568455, A61K 3140, A61K 31325, C07C 4500

Patent

active

057055211

ABSTRACT:
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in radiation oncology applications. The compounds are capable of acting on hemoglobin in whole blood.

REFERENCES:
patent: 4151303 (1979-04-01), Witte et al.
patent: 4153728 (1979-05-01), Wolff et al.
patent: 4482571 (1984-11-01), Abraham
patent: 4699926 (1987-10-01), Abraham et al.
patent: 5049695 (1991-09-01), Abraham et al.
patent: 5122539 (1992-06-01), Abraham et al.
patent: 5248785 (1993-09-01), Abraham et al.
patent: 5290803 (1994-03-01), Abraham et al.
patent: 5431191 (1995-07-01), Abraham et al.

Affiliated with

Also associated with

Rating

Use of allosteric hemoglobin modifiers in combination with radia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of allosteric hemoglobin modifiers in combination with radia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of allosteric hemoglobin modifiers in combination with radia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2329469